UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Type I Interferons in Autoimmune Disease

Annual review of pathology, 2019-01, Vol.14, p.369

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-interferon alpha treatment in SLE

Clinical immunology (Orlando, Fla.), 2013-09, Vol.148 (3), p.303-312

2013

Link zum Volltext

Verfügbarkeit prüfen

Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment

Arthritis & rheumatology (Hoboken, N.J.), 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Targeting of type I interferon in systemic autoimmune diseases

Translational research : the journal of laboratory and clinical medicine, 2015-02, Vol.165 (2), p.296-305

2015

Link zum Volltext

Verfügbarkeit prüfen

Hydroxychloroquine and lupus flare: a good drug, but we need to do better

Annals of the rheumatic diseases, 2022-03, Vol.81 (3), p.303

2022

Link zum Volltext

Verfügbarkeit prüfen

What Causes Lupus Flares?

Current rheumatology reports, 2016-03, Vol.18 (3), p.14, Article 14

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Science translational medicine, 2018-01, Vol.10 (423)

2018

Link zum Volltext

Verfügbarkeit prüfen

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

Lupus, 2024-06, p.9612033241260283-9612033241260283

2024

Link zum Volltext

Verfügbarkeit prüfen

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2686-2696

2016

Link zum Volltext

Verfügbarkeit prüfen

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes

Journal of autoimmunity, 2018-03, Vol.88, p.75-82

2018

Link zum Volltext

Verfügbarkeit prüfen

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations

Rheumatology (Oxford, England), 2023-07, Vol.62 (7), p.2534-2538

2023

Link zum Volltext

Verfügbarkeit prüfen

Low Peripheral B-Cell Counts in Patients With Systemic Rheumatic Diseases Due to Treatment With Belimumab and/or Rituximab Are Associated With Low Antibody Responses to Primary COVID-19 Vaccination

HSS journal, 2023-05, Vol.19 (2), p.180-186

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Arthritis & rheumatology (Hoboken, N.J.), 2021-01, Vol.73 (1), p.121-131

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.740

2017

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients

Arthritis care & research (2010), 2022-04, Vol.74 (4), p.656-664

2022

Link zum Volltext

Verfügbarkeit prüfen

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

Frontiers in immunology, 2022-08, Vol.13, p.980079-980079

2022

Link zum Volltext

Verfügbarkeit prüfen

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1003-1009

2011

Link zum Volltext

Verfügbarkeit prüfen

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

The Journal of experimental medicine, 2022-11, Vol.219 (11)

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.1905-1913

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus

Clinical immunology (Orlando, Fla.), 2016-11, Vol.172, p.34-43

2016

Link zum Volltext

Verfügbarkeit prüfen

Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo

The Journal of immunology (1950), 2009-01, Vol.182 (1), p.34-38

2009

Link zum Volltext

Verfügbarkeit prüfen

Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus

Journal of rheumatology, 2017-07, Vol.44 (7), p.1024

2017

Link zum Volltext

Verfügbarkeit prüfen

Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity

Clinical immunology (Orlando, Fla.), 2021-02, Vol.223, p.108649-108649, Article 108649

2021

Link zum Volltext

Verfügbarkeit prüfen

The Case | Knee pain and allograft dysfunction in a kidney transplant recipient

Kidney international, 2020-02, Vol.97 (2), p.429-430

2020

Link zum Volltext

Verfügbarkeit prüfen

Responsiveness of the Patient‐Reported Outcomes Measurement Information System Global Health Short Form in Outpatients With Systemic Lupus Erythematosus

Arthritis care & research (2010), 2020-09, Vol.72 (9), p.1282-1288

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(95)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(60)
Science & Technology
(60)
Humans
(50)
Rheumatology
(41)
Systemic Lupus Erythematosus
(24)
Female
(22)
Immunology
(20)
Lupus Erythematosus, Systemic - Immunology
(19)
Adult
(16)
Lupus
(16)
Biological And Medical Sciences
(15)
Male
(15)
Lupus Erythematosus, Systemic - Genetics
(14)
Aged
(12)
Medical Sciences
(12)
Middle Aged
(12)
Lupus Erythematosus, Systemic - Blood
(11)
Gene Expression
(10)
Animals
(9)
Autoimmune Diseases
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Type I Interferons in Autoimmune Disease

Anti-interferon alpha treatment in SLE

Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment

Targeting of type I interferon in systemic autoimmune diseases

Hydroxychloroquine and lupus flare: a good drug, but we need to do better

What Causes Lupus Flares?

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes

Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations

Low Peripheral B-Cell Counts in Patients With Systemic Rheumatic Diseases Due to Treatment With Belimumab and/or Rituximab Are Associated With Low Antibody Responses to Primary COVID-19 Vaccination

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE

Venous Thromboembolic Events in African American Lupus Patients in Association With Antiphospholipid Antibodies Compared to White Patients

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus

Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo

Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus

Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity

The Case | Knee pain and allograft dysfunction in a kidney transplant recipient

Responsiveness of the Patient‐Reported Outcomes Measurement Information System Global Health Short Form in Outpatients With Systemic Lupus Erythematosus

Suchergebnisse filtern